Petroleum Technologies Group
Modernizing Data Management and UX for an Industry-Leading Fluid Testing Provider
Design // Development // Storyblok
Cyteir Therapeutics, Inc., founded in 2012 and headquartered in Lexington, Massachusetts, was a clinical-stage biotechnology company focused on developing precision oncology therapies. The company’s lead investigational drug, CYT-0851, was an oral monocarboxylate transporter (MCT) inhibitor designed to disrupt cancer cell metabolism. CYT-0851 advanced to Phase 1/2 clinical trials, showing promising results in combination with capecitabine for treating advanced platinum-resistant ovarian cancer, achieving a disease control rate of 91% in a heavily pretreated patient population
Since the website and brand relaunch, Cyteir has demonstrated strong momentum in both fundraising and team growth. The company has been highly effective in securing new rounds of funding and attracting top-tier talent to support its continued development.
Cyteir Therapeutics, an early-stage life science startup in genetics, discovers and develops novel therapeutics for the treatment of cancer. As they began to pursue new funding sources and recruit more employees, the company faced a challenge: making highly technical content more approachable and engaging for a financial and non-scientific audience.
A website refresh and brand modernization were needed to better position Cyteir within the industry. BizStream rebuilt the corporate website to enhance the standard of its graphics—including an updated company logo—and to support a modern, easy-to-navigate design that includes comprehensive yet clear descriptions of the company’s services. Today, we continue to support Cyteir with intermittent collateral projects.
Stay up to date on what BizStream is doing and keep in the loop on the latest in marketing & technology.
